Understanding the costs of drug-related actions is an important aspect of drug policy. Generally, some of the funds allocated by governments for expenditure on tasks related to drugs are identified as such in the budget (‘labelled’). Often, however, most drug-related expenditure is not identified (‘unlabelled’) and must be estimated using modelling approaches.
The available information does not allow reporting on the size of and trends in drug-related public expenditure in Austria. However, in 2013, a study on the cost of drug dependency estimated that the costs attributable to the use of illicit drugs total EUR 278 million annually. This is made up of healthcare expenditure (EUR 135 million), social expenditure (EUR 51 million) and state expenditure (on police and court activities) (EUR 96 million).